title: The platelets' perspective to pathogen reduction technologies.
abstract: A wide variety of clinical conditions, associated with low circulating platelet counts, require platelet transfusion in order to normalize hemostatic function. Although single-donor apheresis platelets bear the lowest risk of transfusion-transmitted infections, pathogen reduction technologies (PRT) are being implemented worldwide to reduce this risk further through inactivation of known, emergent and as yet to be discovered nucleic acid-based pathogens. Human blood platelets are now known to harbor a diverse transcriptome, important to their function and comprised of >5000 protein-coding messenger RNAs and different classes of non-coding RNAs, including microRNAs. Our appreciation of the nucleic acid-dependent functions of platelets is likely to increase. On the other hand, the side effects of PRT on platelet function are underappreciated. Recent evidences suggest that PRT may compromise platelets' responsiveness to agonists, and induce platelet activation. For instance, platelets have the propensity to release proinflammatory microparticles (MPs) upon activation, and the possibility that PRT may enhance the production of platelet MPs in platelet concentrates (PCs) appears likely. With this in mind, it would be timely and appropriate to investigate other means to inactivate pathogens more specifically, or to modify the currently available PRT so to better preserve the platelet function and improve the safety of PCs; platelets' perspective to PRT deserves to be considered.
authors.affiliation: a Department of Clinical Chemistry , Region Östergötland , Linköping , Sweden.|b Department of Clinical and Experimental Medicine , University of Linköping , Linköping , Sweden.
authors.forename: Abdimajid
authors.initials: A
authors.lastname: Osman
authors.affiliation: c Transfusion Center, University Medical Center of the Johannes Gutenberg University Mainz , Hochhaus Augustusplatz , Mainz , Germany.
authors.forename: Walter E
authors.initials: WE
authors.lastname: Hitzler
authors.affiliation: d CHUQ Research Center/CHUL , 2705 Blvd Laurier, Quebec , QC , Canada.|e Faculty of Medicine , Université Laval , Quebec , QC , Canada.
authors.forename: Patrick
authors.identifier: http://orcid.org/0000-0002-6099-6562
authors.initials: P
authors.lastname: Provost
mesh_terms: D001792:Blood Platelets / Q000166:cytology / Q000502:physiology*; D006801:Humans; D017053:Infection Control / Q000379:methods*; D010979:Platelet Function Tests
keywords: Nucleic acids; RNA transcriptome; pathogen reduction technologies; platelet activation; platelet concentrate